How New SARS-CoV-2 Variants Interact with Human Cells and Vaccines
Neutralization, effector function and immune imprinting of Omicron variants Recent variants of the SARS-CoV-2 virus, such as BQ.1.1 and XBB.1.5, have developed specific mutations in their spike proteins, which affect how the virus interacts with human cells and the effectiveness of vaccines and treatments. This study found that these variants bind more tightly to human…
